Eupraxia Pharmaceuticals (EPRX) EPS (Basic) (2023 - 2026)
Eupraxia Pharmaceuticals' (EPRX) quarterly EPS (Basic) came in at -$0.22 in Q1 2026, down 17.67% year-on-year from -$0.27 in Q1 2025, and down 29.33% on a QoQ basis from -$0.17 in Q3 2025.
Eupraxia Pharmaceuticals (EPRX) EPS (Basic) (2023 - 2026) Analysis & Trends
Eupraxia Pharmaceuticals (EPRX) has 4 years of EPS (Basic) data on file, last reported at -$0.22 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 17.67% year-over-year to -$0.22 in Q1 2026; TTM through Mar 2026 was -$0.49, a 7.16% increase from a year earlier, with the FY2025 full-year figure at -$0.97, down 27.34% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.22, down from -$0.17 in the prior quarter.
- Over the last five years, EPS (Basic) for EPRX reached as high as -$0.17 in Q3 2024 and fell as low as -$0.43 in Q2 2023.
- Historically, EPS (Basic) has averaged -$0.22 across 4 years, with a median of -$0.19 in 2023.
- Across the five-year window, EPS (Basic) soared 60.59% in 2024 and plunged 43.09% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.19 in 2023, then increased by 12.32% to -$0.17 in 2024, then decreased by 2.59% to -$0.17 in 2025, then retreated by 29.33% to -$0.22 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.22 in Q1 2026, -$0.17 in Q3 2025, and -$0.24 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Eupraxia Pharmaceuticals | 357.29 Mn | 355.69 Mn | - | -0.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.22 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.24 |
| Mar 31, 2025 | -0.19 |
| Sep 30, 2024 | -0.17 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.21 |
| Sep 30, 2023 | -0.19 |
| Jun 30, 2023 | -0.43 |
| Mar 31, 2023 | -0.18 |